Identification of genes that are regulated transcriptionally by Myc in childhood tumors
Open Access
- 8 July 2003
- Vol. 98 (4) , 841-853
- https://doi.org/10.1002/cncr.11584
Abstract
BACKGROUND Amplification of the N-myc oncogene is associated with adverse outcomes in the common childhood tumor, neuroblastoma. Because the transforming properties of Myc are related to its ability to modulate gene expression, the authors used cDNA microarrays to identify potential Myc target genes. METHODS Expression levels of 4608 genes were analyzed in a series of neuroblastoma cell lines. Identical analyses were performed in a panel of medulloblastoma cell lines to identify c-Myc targets and to determine the extent to which N-Myc targets and c-Myc targets were shared. Comparisons were made between cell lines with high levels versus low levels of Myc protein expression. RESULTS Array analyses yielded 121 genes with increased expression levels (≥ 1.65-fold) and 9 genes with decreased expression levels in N-Myc-expressing versus nonexpressing cell lines. Many of these were newly identified targets of biologic interest. Fifty percent of the N-Myc targets (60 of 121) were mutual c-Myc targets. A significant correlation between the level of N-myc and selected target gene expression was demonstrated independently in 27 neuroblastoma tumor samples and in an N-myc-inducible cell line system. CONCLUSIONS A number of diverse pathways are modulated by N-Myc in neuroblastoma. Although, overall, there was significant correlation between myc and target transcript expression among cohorts of tumors, great variability in levels of target expression was seen among individual tumor samples, and this biologic heterogeneity in the levels of target gene expression may offer insight into differences in the clinical behavior of neuroblastoma and may prove to be of prognostic significance in the future. Cancer 2003;98:841–53. © 2003 American Cancer Society. DOI 10.1002/cncr.11584Keywords
This publication has 59 references indexed in Scilit:
- ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic valueOncogene, 2003
- Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 2002
- Diversity of the apoptotic response to chemotherapy in childhood leukemiaLeukemia, 2002
- Development of Ribozymes That Target Stathmin, a Major Regulator of the Mitotic SpindleAntisense and Nucleic Acid Drug Development, 2001
- C-MYC expression in medulloblastoma and its prognostic valueInternational Journal of Cancer, 2000
- The ciliary neurotrophic factor and its receptor, CNTFRαPharmaceutica Acta Helvetiae, 2000
- Gene-target recognition among members of the Myc superfamily and implications for oncogenesisNature Genetics, 2000
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Altered growth and phenotype in clonalmycN transfectants of the sk-n-sh neuroblastoma cell lineInternational Journal of Cancer, 1994
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985